InsidersTradesSigma
Total declarations
Companies
▲ Purchases (2 ops.)
▼ Sales (0 ops.)
Browse the full record of transactions filed by DE SCHUTTER RICHARD U, Director. Insider active across 2 companies, notably Bausch Health Companies Inc.. Aggregated, 13 disclosures have been logged. Total volume traded: €423k. The latest transaction was filed on 24 June 2022 — Attribution. Regulator: SEC (Form 4). The full history is openly available.
Declarations13 total
034,387 shares0
Common Shares, No Par Value
SEC:0001127602-22-018203:0·
012,500 shares0
Common Shares, No Par Value
SEC:0000899243-22-017852:0·
€31,0381,504 shares@ €20.6370.0012% mcap4.9% of flow
Common Shares, No Par Value
SEC:0001127602-22-011286:0·
€30,3531,245 shares@ €24.379610.1% of flow
Common Shares, No Par Value
SEC:0001127602-22-000105·
€30,3531,245 shares@ €24.37960.0012% mcap4.8% of flow
Common Shares, No Par Value
SEC:0001127602-22-000105:0·
€29,6921,234 shares@ €24.06169.9% of flow
Common Shares, No Par Value
SEC:0001127602-21-026451·
€29,6921,234 shares@ €24.06160.0012% mcap4.7% of flow
Common Shares, No Par Value
SEC:0001127602-21-026451:0·
€211,29910,000 shares@ €21.129970.4% of flow
Common Shares, No Par Value
SEC:0001127602-21-023267·
Ideal exit: 1 May 2022 (T+270)
€211,29910,000 shares@ €21.12990.0082% mcap33.4% of flow
Common Shares, No Par Value
SEC:0001127602-21-023267:0·
Ideal exit: 1 May 2022 (T+270)
€28,9821,172 shares@ €24.72859.7% of flow
Common Shares, No Par Value
SEC:0001127602-21-021208·
€28,9821,172 shares@ €24.72850.0011% mcap4.6% of flow
Common Shares, No Par Value
SEC:0001127602-21-021208:0·
07,645 shares0
Common Shares, No Par Value
SEC:0001127602-21-014906:0·
07,645 shares0
Common Shares, No Par Value
SEC:0001127602-21-014906·
13 of 13 declarations
About DE SCHUTTER RICHARD U
Richard U. De Schutter is a Director at Bausch Health Companies Inc. and Bausch & Lomb Corp. In this role, he participates in the governance of these companies and strategic decision-making. Richard brings expertise in health and biotechnology, enabling him to contribute to overseeing operations and guiding Bausch Health's strategic direction. His commitment to innovation and efficiency is essential for the success of these companies.
